PATLF
Patrys Limited

0
Price
$0.05
Volume
20,000.00
Open
$0.06
EPS (Annual)
-$0.0101
PATLF Fundamentals
Loading...
Loading...

About

Patrys Ltd. engages in the commercialization of the group's proprietary technologies to develop natural human antibody-based therapeutic products for the treatment of cancer and the pursuit of non-dilutive funding sources. Its pipeline includes PAT-DX1 antibody fragment, PAT-DX3 full sized antibody, and PAT-DX1-NP conjugated to nanoparticles. The company was founded by Daniel Devine on December 8, 2006 and is headquartered in South Melbourne, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Patrys Limited stock price today?

Latest PATLF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.